TY - JOUR T1 - Type 2 diabetes mellitus screening has no effect on mortality JF - Evidence Based Medicine JO - Evid Based Med SP - 136 LP - 136 DO - 10.1136/ebmed-2015-110225 VL - 20 IS - 4 AU - Uzung Yoon Y1 - 2015/08/01 UR - http://ebm.bmj.com/content/20/4/136.abstract N2 - Commentary on: Selph S, Dana T, Blazina I, et al. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2015; 162:765–6.OpenUrlCrossRefPubMedScreening for type 2 diabetes mellitus in asymptomatic persons could lead to early identification and treatment, and potentially result in improved outcomes. In 2008, the U.S. Preventive Services Task Force (USPSTF) recommended diabetes screening in asymptomatic adults with sustained blood pressure (BP) greater than 135/80 mm Hg. Unfortunately, the USPSTF found insufficient evidence to assess the balance of benefits and harms of screening adults without elevated BP. Some evidence supports the use of impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) in identifying high-risk populations.1 Lifestyle and drug interventions in these groups showed beneficial effects for … ER -